Parkinson's Disease Tulip


advertisement
 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 10-03-2017, 02:18 AM #5
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
15 yr Member
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
15 yr Member
Default

I think it would be useful to discuss the following ideas with your doctors.

Keep a diary of the symptoms and relate that to the peaks and troughs of the daily drug regimen. For instance, is the psychosis absent before the first dose of the day, but present a hour after the dose?

A paper by Latoo et al. gives some pointers of how to continue [1]:

"The main extrinsic cause of Parkinson’s disease psychosis is thought to be the medication used to treat the condition ... , although levodopa and catechol-O-methyl transferase (COMT) inhibitors are implicated to a lesser extent than other drugs."

I take this to mean that one should withdraw first agonists, possibly replacing them with levodopa to make up for any motor deficiencies (see posts on levodopa equivalent dose for conversion factors). It may be possible to get some extra benefit from using a COMT inhibitor such as entacapone (Stalevo = levodopa/carbidopa/entacapone). A further benefit may come from smoothing out levodopa plasma levels by taking into account the pharmacokinetic properties of levodopa. Possibly, by reducing the dose, while increasing its frequency.

Reference:

[1] "Diagnosis and management of psychosis in Parkinson’s disease"
Javed Latoo MBBS, DPM, MRCPsych, Minal Mistry BM, BSc, MRCPsych, MSc, PGDipEd, Francis J Dunne MRCPsych, FRCPsych
Progress in Neurology and Psychiatry
Volume 16, Issue 5, Version of Record online: 12 OCT 2012
Diagnosis and management of psychosis in Parkinson's disease - Latoo - 212 - Progress in Neurology and Psychiatry - Wiley Online Library

John
__________________
Born 1955. Diagnosed PD 2005.
Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg
Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg
johnt is offline   Reply With QuoteReply With Quote
 

Tags
α-synuclein, cognitive, decline, patients, plasma


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Algorithm Accurately Predicts Cognitive Decline in Parkinson's Disease - Neurology Ad NewsBot Parkinson's News 0 08-21-2017 01:00 PM
New study finds genetic link between Parkinson's disease and cognitive decline - News NewsBot Parkinson's News 0 12-02-2016 04:50 AM
Cognitive decline seen after deep brain stimulation for Parkinson's disease Stitcher Parkinson's Disease 0 07-15-2008 08:14 AM
Celiac Disease and Cognitive Decline jccgf Alzheimer's Disease 0 03-22-2007 06:58 PM


All times are GMT -5. The time now is 12:49 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.